Halder Venture Board Approves ₹5 Crore Capital Increase and ₹25 Crore Warrant Issuance
Halder Venture Limited's board meeting on March 26, 2026, approved significant corporate actions including a ₹5 crore increase in authorised share capital to ₹18.43 crore and the issuance of 7,93,650 convertible warrants at ₹315 each to P.K. Bio Link Private Limited for ₹24,99,99,750. The board also managed internal auditor transitions, replacing M/s Somnath Ray & Associates with M/s J Kumar Jain & Associates, with all resolutions subject to shareholder approval through postal ballot.

*this image is generated using AI for illustrative purposes only.
Halder Venture Limited has officially concluded its board meeting on March 26, 2026, approving significant corporate actions including capital structure enhancement and fund raising through convertible warrants. The meeting, held at Diamond Heritage, Kolkata, addressed multiple strategic initiatives as outlined in the company's regulatory filing to NSE (Symbol: HALDER) and BSE (Script Code: 539854).
Board Meeting Outcomes
The board of directors approved five key resolutions during the meeting held from 3:00 PM to 4:30 PM at Diamond Heritage, 16 Strand Road, 10th Floor, Unit-1012, Kolkata-700001. The decisions encompass internal auditor changes, capital structure modifications, and fund raising initiatives, all subject to shareholder approval through postal ballot.
| Resolution Type: | Details |
|---|---|
| Meeting Duration: | 3:00 PM to 4:30 PM |
| Venue: | Diamond Heritage, Kolkata |
| Total Resolutions: | 5 approved |
| Regulatory Compliance: | Regulation 30 of SEBI LODR |
Internal Auditor Transition
The board took note of the resignation of M/s Somnath Ray & Associates (FRN: 324411E), Chartered Accountants, as Internal Auditor effective March 18, 2026, due to increased professional commitments and work pressures. Subsequently, the board approved the appointment of M/s J Kumar Jain & Associates (FRN: 330168E), Chartered Accountants, as the new Internal Auditor for Financial Year 2025-2026.
| Auditor Details: | Outgoing | Incoming |
|---|---|---|
| Firm Name: | M/s Somnath Ray & Associates | M/s J Kumar Jain & Associates |
| FRN: | 324411E | 330168E |
| Cessation Date: | March 18, 2026 | - |
| Appointment Date: | - | March 26, 2026 |
| Reason: | Pre-occupation | New appointment |
Authorised Share Capital Enhancement
The board approved a substantial increase in the company's authorised share capital from ₹13.43 crore to ₹18.43 crore, representing an addition of ₹5.00 crore. This enhancement involves creating 50,00,000 additional equity shares of ₹10 each, bringing the total authorised shares to 1,84,25,000 equity shares.
| Capital Structure: | Current | Proposed |
|---|---|---|
| Authorised Capital: | ₹13.43 crore | ₹18.43 crore |
| Number of Shares: | 1,34,25,000 | 1,84,25,000 |
| Additional Shares: | - | 50,00,000 |
| Face Value: | ₹10 per share | ₹10 per share |
Convertible Warrants Issuance
The board approved the creation and issuance of 7,93,650 convertible warrants with a face value of ₹10 each at a price of ₹315 per warrant, including a premium of ₹305. The entire warrant allocation will be made to P.K. Bio Link Private Limited, a non-promoter entity, for a total consideration of ₹24,99,99,750.
| Warrant Details: | Specifications |
|---|---|
| Total Warrants: | 7,93,650 |
| Face Value: | ₹10 per warrant |
| Issue Price: | ₹315 per warrant |
| Premium: | ₹305 per warrant |
| Total Amount: | ₹24,99,99,750 |
| Allottee: | P.K. Bio Link Private Limited |
| Category: | Non-Promoter |
| Issuance Type: | Preferential allotment |
Regulatory Compliance and Implementation
All approved resolutions are subject to shareholder approval through postal ballot, for which the board has also approved the postal ballot notice. The regulatory filing was digitally signed by Ayanti Sen, Company Secretary and Compliance Officer, ensuring compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company operates under CIN No.: L74210WB1982PLC035117 and maintains its headquarters at Diamond Heritage, Kolkata.
Historical Stock Returns for Halder Venture
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.53% | -2.30% | -6.79% | -9.24% | -9.24% | -9.24% |
What strategic initiatives will Halder Venture pursue with the ₹25 crore raised through convertible warrants?
How might the significant stake acquisition by P.K. Bio Link Private Limited influence Halder Venture's future business direction and governance?
Will the 37% increase in authorized share capital signal additional fundraising rounds or expansion plans beyond the current warrant issuance?


































